M&A in Israel – Were they right?


I was looking for information on M&A in Israel and I found this interesting forecast by Morgan Stanley (MA) from 2001. Many things changed politically and economically since the forecast was put together, but it’s still very much relevant.

Israel: Venture Capital — The Technology Incubator

Serhan Cevik (London)

This is an excerpt from a country report on the Israeli economy, Technology – Deus Ex Machina, 24 pp, 12 February 2001.

Get ready for the M&A boom in Israel. The amount of mergers and acquisitions (M&A) around the world reached US$3.5 trillion in 2000, according to Thomson Financial Securities Data. In the meantime, the value and number of M&A deals in Israel rose to 302 and US$11.0 billion in 2000, from 274 and US$9.6 billion in the previous year. Industry sources expect a slowdown in worldwide M&A activity this year on the back of falling equity prices. Especially, the technology, media and telecommunications (TMT) sector, which accounted for 40% of worldwide M&A deals in 2000, is likely to go through a hibernation period. Nevertheless, we expect the wave of consolidation in emerging markets to remain relatively unbreakable, as the coming economic slowdown puts tremendous pressure on companies to restructure. Moreover, many Israeli start-ups are getting mature enough to become attractive targets for M&A. For example, Lucent Technologies, an American giant in the communications technology sector, recently took over Chromatis Networks, an Israeli company specialising in optical equipment, for US$4.5 billion. We expect the number of M&A deals targeting Israeli companies to grow considerably in 2001 and beyond, and directly (or indirectly) to attract capital flows to the country.

In conclusion – Chromatis might not exist anymore, but Warren Buffet’s 4B in Iscar and the record investment level in Israeli startups kept the country on the map.

More of these to come, I appreciate your feedback!

Eze

Eze Vidra
Follow me

Eze Vidra

Chief Innovation Officer at Antidote
Eze is the Chief Innovation Officer at Antidote, a startup helping patients search and match to clinical trial, to accelerate medical breakthroughs. Previously, Ezewas a General Partner at Google Ventures Europe. Before GV, Eze founded and led Campus London, Google's first physical hub for startups, and was the Head Google for Entrepreneurs in Europe. He's an experienced product manager and startup mentor. In 2012 Eze founded Techbikers, a non-for profit supporting children education in developing countries.
Eze Vidra
Follow me

Latest posts by Eze Vidra (see all)

Eze Vidra

Eze is the Chief Innovation Officer at Antidote, a startup helping patients search and match to clinical trial, to accelerate medical breakthroughs. Previously, Eze was a General Partner at Google Ventures Europe. Before GV, Eze founded and led Campus London, Google's first physical hub for startups, and was the Head Google for Entrepreneurs in Europe. He's an experienced product manager and startup mentor. In 2012 Eze founded Techbikers, a non-for profit supporting children education in developing countries.

Comments are closed.